Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
977
Sort by:
Global Hyperimmune Globulins Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Hyperimmune Globulins, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...
January 2026
117 pages
Global Human Rabies Immunoglobulin (IM) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... of the Report: This report focuses on the Human Rabies Immunoglobulin (IM) in global market, especially in North America, Europe, Asia ... 15 Chapters to deeply display the global Human Rabies Immunoglobulin (IM) market. Chapter 1, to describe Human Rabies Immunoglobulin (IM) Introduction, product scope, market ...
January 2026
115 pages
Global Zika Virus Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... are 15 Chapters to deeply display the global Zika Virus market. Chapter 1, to describe Zika Virus Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...
January 2026
105 pages
Global Rabies Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Rabies Vaccine, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...
January 2026
86 pages
The 2027-2032 World Outlook for Clostridium Vaccines
US$ 1,195.00
This study covers the world outlook for clostridium vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Conjugate Vaccines
US$ 1,195.00
This study covers the world outlook for conjugate vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for COVID-19 Vaccines
US$ 1,195.00
This study covers the world outlook for COVID-19 vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Dengue Vaccines
US$ 1,195.00
This study covers the world outlook for dengue vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Flu Vaccines
US$ 1,195.00
This study covers the world outlook for flu vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for H1N1 2009 Influenza Vaccines
US$ 1,195.00
This study covers the world outlook for H1N1 2009 influenza vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for H1N1 (Swine Flu) Vaccination
US$ 1,195.00
This study covers the world outlook for H1N1 (swine flu) vaccination across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Hepatitis B Vaccines
US$ 1,195.00
This study covers the world outlook for hepatitis b vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for HPV Vaccines
US$ 1,195.00
This study covers the world outlook for HPV vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Infectious Disease Vaccines
US$ 1,195.00
This study covers the world outlook for infectious disease vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
287 pages
The 2027-2032 World Outlook for Live Vaccines
US$ 1,195.00
This study covers the world outlook for live vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
The 2027-2032 World Outlook for Meningitis Vaccines
US$ 1,195.00
This study covers the world outlook for meningitis vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Mono Hepatitis B Vaccines
US$ 1,195.00
This study covers the world outlook for mono hepatitis B vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Norovirus Vaccines
US$ 1,195.00
This study covers the world outlook for norovirus vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Paediatric Vaccines
US$ 1,195.00
This study covers the world outlook for paediatric vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Plant-Based Vaccines
US$ 1,195.00
This study covers the world outlook for plant-based vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Pneumococcal Vaccines
US$ 1,195.00
This study covers the world outlook for pneumococcal vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Pneumonia Vaccines
US$ 1,195.00
This study covers the world outlook for pneumonia vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Rabies Treatments
US$ 1,195.00
This study covers the world outlook for rabies treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Recombinant Vaccines
US$ 1,195.00
This study covers the world outlook for recombinant vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Vaccines Sales
US$ 1,195.00
This study covers the world outlook for vaccines sales across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
